OpenEvidence Launches Legal Battle to Safeguard AI Trade Secrets Amid Industry Rivalry

OpenEvidence, a Canadian company specializing in artificial intelligence for medical information, has initiated legal proceedings in a Massachusetts federal court, accusing a competitor of attempting to access its trade secrets. The lawsuit alleges that the rival company employed misappropriated personal information along with sophisticated prompts to extract confidential details from OpenEvidence’s platform. In its pursuit to protect what it describes as its “crown jewel” source code, OpenEvidence’s strategic legal action highlights ongoing challenges in protecting proprietary technology in the competitive AI sector. For further details, visit the Law360 article.